• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

pregabalin - Articles and news items

Pfizer logo

Pfizer reports top-line results from a Phase 3 study evaluating pregabalin controlled-release formulation as a treatment for patients with postherpetic neuralgia

Industry news / 19 December 2014 / Pfizer

Pfizer Inc. announced top-line results from a double-blind Phase 3 study evaluating pregabalin controlled-release (CR) formulation in adult patients with postherpetic neuralgia…

Pfizer logo

Pfizer reports top-line results from two Lyrica® capsules CV phase 3b studies

Industry news / 18 October 2013 / Pfizer Inc

The study met its primary endpoint, showing a statistically significant greater reduction in fibromyalgia pain…

Pfizer logo
Pfizer logo
Pfizer logo

Pfizer and Northwestern University win LYRICA® patent case

Industry news, News / 19 July 2012 / Pfizer

“The Court’s decision recognizes the infringement & validity of our LYRICA® patents…”

Pfizer logo
Pfizer logo

Pfizer stops Phase 3 trial Of Lyrica (pregabalin) capsules CV in neuropathic pain associated with HIV neuropathy

Industry news, News / 4 May 2012 / Pfizer

Pfizer has stopped a Phase 3 clinical trial of Lyrica in patients with neuropathic pain…

Pfizer logo
Pfizer logo

Positive top-line results for Pfizer’s Lyrica in Phase 3 Study of patients with Fibromyalgia in Japan

Industry news, News / 5 July 2011 / Pfizer

Pfizer Japan announced the top-line results for Lyrica (pregabalin) Study A0081208…

Pfizer logo

Pfizer’s Lyrica top-line results positive in global Phase 3 Study

Industry news, News / 21 June 2011 / Pfizer

Pfizer Inc. announced that top-line results for Lyrica Study A0081107, demonstrated that the study met its primary endpoint…

 

Webinar: Use of MicroNIR to optimise fluid bed drying and to reduce waste at tablet compressionWATCH NOW
+ +